MedPath

康哲(湖南)制药有限公司

Ownership
-
Established
1996-05-21
Employees
-
Market Cap
-
Website
http://www.cms.net.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

NMPA:44

Drug Approvals

Terbinafine Hydrochloride Tablets

Product Name
盐酸特比萘芬片
Approval Number
国药准字H20184160
Approval Date
Jul 5, 2023
NMPA

Protein Hydrolysate Oral Solution

Product Name
水解蛋白口服溶液
Approval Number
国药准字H45021238
Approval Date
May 18, 2020
NMPA

Protein Hydrolysate Powder

Product Name
水解蛋白散
Approval Number
国药准字H45021316
Approval Date
May 18, 2020
NMPA

肝复乐片

Approval Number
国药准字Z10940066
Approval Date
Nov 27, 2019
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H43021697
Approval Date
Aug 29, 2019
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20033435
Approval Date
May 26, 2016
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20033436
Approval Date
May 26, 2016
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H43021669
Approval Date
May 26, 2016
NMPA

Naloxone Hydrochloride Injection

Product Name
金尔伦
Approval Number
国药准字H20033437
Approval Date
May 26, 2016
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H43021696
Approval Date
Mar 23, 2016
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.